Press release
Statins Market worth $47.08 billion by 2030, growing at a CAGR of 5.85% - Exclusive Report by 360iResearch
Statins Market | 360iResearch
The Global Statins Market to grow from USD 31.61 billion in 2023 to USD 47.08 billion by 2030, at a CAGR of 5.85%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/statins?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Statins are a class of lipid-lowering medications that deter the enzyme HMG-CoA reductase, which plays a vital role in the formation of cholesterol in the liver. Statins help prevent cardiovascular diseases, including heart attacks and strokes, by reducing the levels of low-density lipoprotein (LDL) cholesterol in the blood. The primary drivers for statins include the rising prevalence of cardiovascular disorders, increasing awareness of the risks associated with high cholesterol, and a growing aging population that is more susceptible to heart diseases. Additionally, the recommendation of statins in national guidelines for preventing cardiovascular events contributes to their increased demand. Statin market faces the challenges consisting of patent expirations of leading drugs, leading to competition from generic alternatives and price erosion. Concerns over side effects such as muscle pain and the increasing adoption of alternative treatment options also pose significant challenges to the growth of statin adoption. New opportunities in the statin market are emerging from ongoing research and development that aim to improve efficacy and reduce side effects. The development of combination drugs that pair statins with other cardiovascular agents offers potential for growth. Moreover, emerging economies with increasing healthcare spending represent a significant opportunity for the expansion of the statin.
Market Segmentation & Coverage:
This research report categorizes the Statins Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Type, market is studied across Natural Statins and Synthetic Statins. The Natural Statins is projected to witness significant market share during forecast period.
Based on Drug Class, market is studied across Atorvastatin, Fluvastatin, Lovastatin, Pitavastatin, Rosuvastatin, and Simvastatin. The Simvastatin is projected to witness significant market share during forecast period.
Based on Application, market is studied across Attacks, Cardiovascular Diseases, Diabetes, Heart Strokes, Inflammation, Lifestyle Diseases, and Obesity. The Heart Strokes is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Clinics and Hospitals. The Hospitals is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Statins Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Statins Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Statins Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Amgen Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Becton, Dickinson and Company, Biocon Limited, bioMérieux S.A., Centrient Pharmaceuticals Netherlands B.V., Concord Biotech Limited, Danaher Corporation, DiaSorin S.p.A., F. Hoffman-La Roche AG, GlaxoSmithKline PLC, Grifols, S.A., Merck & Co., Inc., Nova Biomedical, Novartis AG, Pfizer Inc., Quidel Corporation, Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., and Trinity Biotech PLC.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/statins?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Statins Market, by Type
7. Statins Market, by Drug Class
8. Statins Market, by Application
9. Statins Market, by End-User
10. Americas Statins Market
11. Asia-Pacific Statins Market
12. Europe, Middle East & Africa Statins Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Statins Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Statins Market?
3. What is the competitive strategic window for opportunities in the Statins Market?
4. What are the technology trends and regulatory frameworks in the Statins Market?
5. What is the market share of the leading vendors in the Statins Market?
6. What modes and strategic moves are considered suitable for entering the Statins Market?
Read More @ https://www.360iresearch.com/library/intelligence/statins?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Statins Market worth $47.08 billion by 2030, growing at a CAGR of 5.85% - Exclusive Report by 360iResearch here
News-ID: 3373623 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Statin
Statin Market Size Set for Steady Growth Amid Rising Cardiovascular Health Conce …
Statin Market Poised for Steady Growth Amid Rising Cardiovascular Concerns The statin market is experiencing consistent growth, driven by the increasing prevalence of cardiovascular diseases (CVDs) and heightened awareness about cholesterol management. This press release delves into the market's current valuation, growth drivers, opportunities, recent trends in the U.S. market, key market segments, competitive landscape, and regional dynamics in major countries.
Request Sample Link For More Details: https://www.maximizemarketresearch.com/request-sample/77560/
Market…
Statin Market is Anticipated to Hit USD 18.93 Billion by 2030
The 𝐒𝐭𝐚𝐭𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 was valued USD 15.39 Bn in 2023 and is expected to reach USD 18.93 Bn by 2030, at a CAGR of 3% during a forecast period.
𝐒𝐭𝐚𝐭𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
Statins are widely used for the prevention and treatment of atherosclerosis, a condition that can lead to chest pain, heart attacks, and strokes. These medications primarily function by lowering low-density lipoprotein (LDL) cholesterol levels in the body, making them essential…
Statin Market Expecting Huge Demand in Upcoming Years |Amgen, Biocon, AstraZenec …
Statin Market is the latest research study released by USD Analytics Market evaluating the market, size, share, sales, highlighting opportunities, risk analysis, and leveraging with strategic and tactical decision-making support. The factors that impact growth and rules concerning the use of information, the accessibility of dependable products in the market, and the enhancement of operational efficiency among players in Statin. Information on market development, trends, capabilities, technologies, and the shifting…
Statin Market is forecasted to expand to USD 18.93 Billion by 2030
Anticipated Growth in Revenue:
Statin Market was valued USD 15.39 Bn in 2023 and is expected to reach USD 18.93 Bn by 2030, at a CAGR of 3% during a forecast period.
Statin Market Overview:
The statin market encompasses pharmaceutical drugs primarily used to lower cholesterol levels in patients at risk of cardiovascular diseases. Statins work by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol synthesis in the liver.…
Statin Market Share, Trends, Key Drivers, Demand, Opportunities,Technologies and …
The statin market, projected to reach USD 22.21 billion by 2030 with a CAGR of 4.70% during 2023-2030, is driven by increasing cholesterol incidence due to lifestyle changes. Statins, pharmaceutical drugs prescribed to reduce cholesterol levels, are witnessing high demand globally due to urbanization and rising awareness about cholesterol-related disorders.
Market Overview:
• The market is driven by increasing cholesterol-related disorders due to lifestyle changes and advanced healthcare facilities.
• Common statins include Atorvastatin, Lovastatin,…
Statin Market To Cross US$ 20.0 Billion by 2032
According to latest report by IMARC Group, titled "Statin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032," The global statin market size reached US$ 15.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032.
Global Statin Market Trends and Growth:
The global statin market is majorly driven by the rising prevalence of…
